Rhumbline Advisers Boosts Holdings in DocGo Inc. (NASDAQ:DCGO)

Rhumbline Advisers raised its position in DocGo Inc. (NASDAQ:DCGO) by 4.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 142,762 shares of the company’s stock after buying an additional 6,204 shares during the quarter. Rhumbline Advisers’ holdings in DocGo were worth $605,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of DCGO. Centiva Capital LP purchased a new stake in shares of DocGo in the third quarter valued at about $43,000. Intech Investment Management LLC acquired a new stake in DocGo in the third quarter valued at about $62,000. Victory Capital Management Inc. boosted its holdings in DocGo by 100.3% in the 3rd quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock valued at $170,000 after purchasing an additional 25,714 shares in the last quarter. SG Americas Securities LLC increased its position in DocGo by 12.9% during the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock worth $183,000 after purchasing an additional 4,905 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of DocGo by 151.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock worth $365,000 after buying an additional 66,097 shares in the last quarter. Hedge funds and other institutional investors own 56.44% of the company’s stock.

DocGo Stock Up 3.4 %

Shares of DCGO stock opened at $3.03 on Friday. DocGo Inc. has a fifty-two week low of $2.75 and a fifty-two week high of $5.68. The business has a fifty day simple moving average of $4.48 and a 200-day simple moving average of $4.00. The stock has a market cap of $309.21 million, a P/E ratio of 10.82, a P/E/G ratio of 14.16 and a beta of 1.08.

Insider Buying and Selling at DocGo

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $4.44, for a total value of $102,510.72. Following the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at $779,863.80. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on DCGO. Deutsche Bank Aktiengesellschaft downgraded DocGo from a “buy” rating to a “hold” rating and decreased their price target for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday, February 28th. Finally, Needham & Company LLC lowered their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $4.89.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.